“Exploring the potential of rivaroxaban in children with cancer: advantages over standard anticoagulants”, Вопр. онкол., vol. 69, no. 3, pp. 399–405, Jun. 2023, doi: 10.37469/0507-3758-2023-69-3-399-405.